Wiley Bros. Aintree Capital, LLC Lantheus Holdings, Inc. Transaction History
Wiley Bros. Aintree Capital, LLC
- $12.5 Billion
- Q2 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 18,394 shares of LNTH stock, worth $1.06 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,394
Previous 9,302
97.74%
Holding current value
$1.06 Million
Previous $907,000
65.93%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding LNTH
# of Institutions
523Shares Held
78.5MCall Options Held
710KPut Options Held
433K-
Black Rock Inc. New York, NY8.6MShares$496 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X06.94MShares$400 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.84MShares$394 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA6.72MShares$388 Million2.47% of portfolio
-
State Street Corp Boston, MA2.56MShares$148 Million0.01% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $3.97B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...